Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004153 · ClinicalTrials.gov registry record · NA
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT00004153 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 106 participants.
The verdict
NCT00004153, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures may improve the ability to detect the presence or recurrence of disease. PURPOSE: Diagnostic trial to detect melanoma markers in the lymph nodes or peripheral blood of patients who have melanoma.
Interventions
- GENETIC reverse transcriptase-polymerase chain reaction
- PROCEDURE sentinel lymph node biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 1998-06 |
| Est. Completion | 2005-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004153
The ClinicalTrials.gov registry entry for NCT00004153 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which reverse transcriptase-polymerase chain reaction is the first listed.
NCT00004153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004153 about?
NCT00004153 is a clinical study titled "Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma". RATIONALE: Diagnostic procedures may improve the ability to detect the presence or recurrence of disease. PURPOSE: Diagnostic trial to detect melanoma markers in the lymph nodes or peripheral blood of patients who have melanoma.
What is the current status of trial NCT00004153?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 1998-06. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00004153?
The interventions under investigation include: reverse transcriptase-polymerase chain reaction (GENETIC), sentinel lymph node biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00004153?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.